Shanghai Shyndec Pharmaceutical Co., Ltd. 600420.SS Stock
Shanghai Shyndec Pharmaceutical Co., Ltd. Price Chart
Shanghai Shyndec Pharmaceutical Co., Ltd. 600420.SS Financial and Trading Overview
Contents
- Shanghai Shyndec Pharmaceutical Co., Ltd. Price Chart
- Shanghai Shyndec Pharmaceutical Co., Ltd. 600420.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Shyndec Pharmaceutical Co., Ltd.
- Q&A For Shanghai Shyndec Pharmaceutical Co., Ltd. Stock
Shanghai Shyndec Pharmaceutical Co., Ltd. stock price | 9.42 CNY |
Previous Close | 11.11 CNY |
Open | 11.15 CNY |
Bid | 11.38 CNY x 0 |
Ask | 11.39 CNY x 0 |
Day's Range | 11.14 - 11.64 CNY |
52 Week Range | 8.24 - 14.3 CNY |
Volume | 14.34M CNY |
Avg. Volume | 18.28M CNY |
Market Cap | 15.14B CNY |
Beta (5Y Monthly) | 0.264041 |
PE Ratio (TTM) | 18.67213 |
EPS (TTM) | 0.54 CNY |
Forward Dividend & Yield | 0.1 (0.88%) |
Ex-Dividend Date | July 29, 2022 |
1y Target Est | N/A |
600420.SS Valuation Measures
Enterprise Value | 12.52B CNY |
Trailing P/E | 18.67213 |
Forward P/E | 11.058253 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.1526546 |
Price/Book (mrq) | 1.2733371 |
Enterprise Value/Revenue | 0.953 |
Enterprise Value/EBITDA | 6.941 |
Trading Information
Shanghai Shyndec Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.264041 |
52-Week Change | 23.03% |
S&P500 52-Week Change | 20.43% |
52 Week High | 14.3 CNY |
52 Week Low | 8.24 CNY |
50-Day Moving Average | 12.38 CNY |
200-Day Moving Average | 10.24 CNY |
600420.SS Share Statistics
Avg. Volume (3 month) | 18.28M CNY |
Avg. Daily Volume (10-Days) | 14.66M CNY |
Shares Outstanding | 1.33B |
Float | 459.46M |
Short Ratio | N/A |
% Held by Insiders | 58.42% |
% Held by Institutions | 0.42% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.1 |
Trailing Annual Dividend Yield | 0.90% |
5 Year Average Dividend Yield | 94.00% |
Payout Ratio | 0.16350001 |
Last Split Factor | 20:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.55% |
Operating Margin (ttm) | 7.36% |
Gross Margin | 37.08% |
EBITDA Margin | 13.73% |
Management Effectiveness
Return on Assets (ttm) | 3.14% |
Return on Equity (ttm) | 8.77% |
Income Statement
Revenue (ttm) | 13.13B CNY |
Revenue Per Share (ttm) | 12.35 CNY |
Quarterly Revenue Growth (yoy) | 5.29% |
Gross Profit (ttm) | 12.96B CNY |
EBITDA | 1.8B CNY |
Net Income Avi to Common (ttm) | 729.39M CNY |
Diluted EPS (ttm) | 0.61 |
Quarterly Earnings Growth (yoy) | 130.90% |
Balance Sheet
Total Cash (mrq) | 5.38B CNY |
Total Cash Per Share (mrq) | 4.59 CNY |
Total Debt (mrq) | 2.64B CNY |
Total Debt/Equity (mrq) | 21.22 CNY |
Current Ratio (mrq) | 2.993 |
Book Value Per Share (mrq) | 8.945 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.71B CNY |
Levered Free Cash Flow (ttm) | 1.88B CNY |
Profile of Shanghai Shyndec Pharmaceutical Co., Ltd.
Country | China |
State | N/A |
City | Shanghai |
Address | No. 378, Jianlu Road |
ZIP | 200137 |
Phone | 86 21 6251 0990 |
Website | https://www.shyndec.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 11492 |
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, raw materials, and pharmaceutical preparations in China and internationally. The company's pharmaceutical intermediate products primarily includes 7-ACA, 6-APA, penicillin industrial salt, etc.; API products for anti-infection applications comprising azithromycin, amoxicillin, potassium clavulanate, ceftriaxone sodium, etc., as well as urine source biochemical products and other characteristic raw materials; pharmaceutical preparations, such as cardiovascular and cerebrovascular drugs that comprises enalapril maleate tablets and nifedipine controlled-release tablets; and anti-aging drugs, including cefuroxime axetil and cefuroxime sodium; and metabolic and endocrine drugs consist if methylprednisolone sodium succinate through injections. Its products portfolio covers systemic anti-infection, heart and brain blood vessels, anti-tumor and immunomodulators, central nervous system, hormones, genitourinary system, digestive tract and metabolism, respiratory system, and other therapeutic areas in various dosage forms, such as tablets, capsules, powder injections, small volume injections, granules, suspensions, suppositories, and ointments. The company also offers animal vaccines and general health products. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Shanghai, China.
Q&A For Shanghai Shyndec Pharmaceutical Co., Ltd. Stock
What is a current 600420.SS stock price?
Shanghai Shyndec Pharmaceutical Co., Ltd. 600420.SS stock price today per share is 9.42 CNY.
How to purchase Shanghai Shyndec Pharmaceutical Co., Ltd. stock?
You can buy 600420.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Shyndec Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Shanghai Shyndec Pharmaceutical Co., Ltd. is 600420.SS.
Which industry does the Shanghai Shyndec Pharmaceutical Co., Ltd. company belong to?
The Shanghai Shyndec Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shanghai Shyndec Pharmaceutical Co., Ltd. have in circulation?
The max supply of Shanghai Shyndec Pharmaceutical Co., Ltd. shares is 1.34B.
What is Shanghai Shyndec Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Shyndec Pharmaceutical Co., Ltd. PE Ratio is 17.44444500 now.
What was Shanghai Shyndec Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Shyndec Pharmaceutical Co., Ltd. EPS is 0.54 CNY over the trailing 12 months.
Which sector does the Shanghai Shyndec Pharmaceutical Co., Ltd. company belong to?
The Shanghai Shyndec Pharmaceutical Co., Ltd. sector is Healthcare.